*SB0209.1*
January 21, 2022
SENATE BILL No. 209
_____
DIGEST OF SB 209 (Updated January 18, 2022 12:54 pm - DI 106)
Citations Affected: IC 35-31.5; IC 35-48.
Synopsis: Drug schedules. Adds specified substances to the scheduled
list of controlled substances.
Effective: July 1, 2022.
Young M
January 6, 2022, read first time and referred to Committee on Corrections and Criminal
Law.
January 20, 2022, amended, reported favorably — Do Pass.
SB 209—LS 6921/DI 92 January 21, 2022
Second Regular Session of the 122nd General Assembly (2022)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in this style type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2021 Regular Session of the General Assembly.
SENATE BILL No. 209
A BILL FOR AN ACT to amend the Indiana Code concerning
criminal law and procedure.
Be it enacted by the General Assembly of the State of Indiana:
1 SECTION 1. IC 35-31.5-2-321, AS AMENDED BY P.L.61-2020,
2 SECTION 2, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
3 JULY 1, 2022]: Sec. 321. "Synthetic drug" means:
4 (1) a substance containing one (1) or more of the following
5 chemical compounds, including an analog of the compound:
6 (A) JWH-015 ((2-Methyl-1-propyl-1H-
7 indol-3-yl)-1-naphthalenylmethanone).
8 (B) JWH-018 (1-pentyl-3-(1-naphthoyl)indole).
9 (C) JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole).
10 (D) JWH-073 (naphthalen-1-yl-(1-butylindol-3-yl)methanone).
11 (E) JWH-081 (4-methoxynaphthalen- 1-yl- (1-pentylindol-
12 3-yl)methanone).
13 (F) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
14 (G) JWH-200 ((1-(2-morpholin-4-ylethyl)indol-3-yl)-
15 naphthalen-1-yl-methanone).
16 (H) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole).
17 (I) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole).
SB 209—LS 6921/DI 92 2
1 (J) JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
2 (K) HU-210 ((6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl-
3 3-(2-methyloctan-2-yl)-
4 6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol).
5 (L) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl-
6 3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo
7 [c]chromen-1-ol).
8 (M) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-
9 (2-methyloctan- 2-yl)phenyl]-
10 7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).
11 (N) HU-331 (3-hydroxy-2- [(1R,6R)-3-methyl-6-
12 (1-methylethenyl)-2 -cyclohexen-1-yl]-5
13 -pentyl-2,5-cyclohexadiene-1,4-dione).
14 (O) CP 55,940
15 (2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-
16 5- (2-methyloctan-2-yl)phenol).
17 (P) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5-
18 (2-methyloctan-2-yl)phenol) and its homologues, or
19 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)
20 phenol), where side chain n=5, and homologues where side
21 chain n=4, 6, or 7.
22 (Q) WIN 55212-2
23 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)
24 pyrrolo [1,2,3-de)- 1,4- benzoxazin-
25 6-yl]-1-napthalenylmethanone).
26 (R) RCS-4 ((4-methoxyphenyl)
27 (1-pentyl-1H-indol-3-yl)methanone).
28 (S) RCS-8 (1-(1-(2-cyclohexylethyl)-1H-
29 indol-3-yl)-2-(2-methoxyphenyl)ethanone).
30 (T) 4-Methylmethcathinone. Other name: mephedrone.
31 (U) 3,4-Methylenedioxymethcathinone. Other name:
32 methylone.
33 (V) Fluoromethcathinone.
34 (W) 4-Methoxymethcathinone. Other name: methedrone.
35 (X) 4-Ethylmethcathinone (4-EMC).
36 (Y) Methylenedioxypyrovalerone. Other name: MDPV.
37 (Z) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole.
38 (AA) JWH-098, or
39 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole.
40 (BB) JWH-164, or
41 1-pentyl-3-(7-methoxy-1-naphthoyl)indole.
42 (CC) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole.
SB 209—LS 6921/DI 92 3
1 (DD) JWH-201, or
2 1-pentyl-3-(4-methoxyphenylacetyl)indole.
3 (EE) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole.
4 (FF) AM-694, or
5 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
6 (GG) CP 50,556-1, or
7 [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpe
8 ntan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1
9 -yl] acetate.
10 (HH) Dimethylheptylpyran, or DMHP.
11 (II) 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP.
12 (JJ) 6-APB [6-(2-aminopropyl)benzofuran].
13 (LL) 7-hydroxymitragynine.
14 (MM) á-PPP [á-pyrrolidinopropiophenone].
15 (NN) á-PVP (desmethylpyrovalerone).
16 (OO) AM-251.
17 (PP) AM-1241.
18 (QQ) AM-2201.
19 (RR) AM-2233.
20 (SS) Buphedrone (á-methylamino-butyrophenone (MABP)).
21 (TT) Butylone.
22 (UU) CP-47,497-C7.
23 (VV) CP-47,497-C8.
24 (WW) Desoxypipradol.
25 (XX) Ethylone.
26 (YY) Eutylone.
27 (ZZ) Flephedrone.
28 (AAA) JWH-011.
29 (BBB) JWH-020.
30 (CCC) JWH-022.
31 (DDD) JWH-030.
32 (EEE) JWH-182.
33 (FFF) JWH-302.
34 (GGG) MDAI [5,6-methylenedioxy-2-aminoindane].
35 (HHH) Mitragynine.
36 (III) Naphyrone.
37 (JJJ) Pentedrone.
38 (LLL) Pentylone.
39 (MMM) Methoxetamine
40 [2-(3-methoxyphenyl)-2-(ethylamino)- cyclohexanone].
41 (NNN) A796,260 [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-
42 (2,2,3,3-tetramethylcyclopropyl)methanone].
SB 209—LS 6921/DI 92 4
1 (OOO) AB-001[(1s,3s)-admantan-1-yl)
2 (1-pentyl-1H-indol-3-yl)methanone] or [1-Pentyl-3-
3 (1-adamantoyl)indole].
4 (PPP) AM-356 [Methanandamide].
5 (QQQ) AM 1248 [1-[(1-methyl-2- piperidinyl) methyl]-
6 1H-indol-3-yl] tricyclo[3.3.1.13,7] dec-1-yl-methanone]or
7 [(1-[(N-methylpiperindin-2-yl)
8 Methyl]-3-(Adamant-1-oyl)indole)].
9 (RRR) AM 2233 Azepane isomer [(2-iodophenyl)
10 (1-(1-methylazepan-3-yl)- 1H-indol-3-yl)methanone].
11 (SSS) CB-13 [1-Naphthalenyl
12 [4-(pentyoxy)- 1-naphthalenyl]methanone].
13 (TTT) UR-144 [(1-pentyl-1H-indol-3-yl)
14 (2,2,3,3-tetramethylcyclopropyl)-methanone].
15 (UUU) URB 597 [(3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)-
16 cyclohexylcarbamate].
17 (VVV) URB602 [[1,1'-biphenyl]- 3-yl-carbamic acid,
18 cyclohexyl ester].
19 (WWW) URB 754 [6-methyl-2-[(4-methylphenyl)
20 amino]-1-benzoxazin-4-one].
21 (XXX) XLR-11 or 5-fluoro UR-144
22 (1-(5-fluoropentyl)-1H-indol-3-yl)
23 (2,2,3,3-tetramethylcyclopropyl)methanone].
24 (YYY) AKB48 (Other names include:
25 N-Adamantyl-1-pentyl-1H-Indazole-3-carboxamide;
26 1-pentyl-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-indazole-3-
27 carboxamide).
28 (ZZZ) 25I-NBOMe (Other names include:
29 4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-
30 benzeneethanamine);
31 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
32 methyl]ethanamine).
33 (AAAA) 2C-C-NBOMe (Other names include: 25C-NBOMe;
34 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
35 methyl]ethanamine;
36 2,5-Dimethoxy-4-chloro-N-(2-methoxybenzyl)
37 phenethylamine).
38 (BBBB) 2NE-1 (Other names include: 1-Pentyl-3-
39 (1-adamantylamido)indole).
40 (CCCC) STS-135 (Other names include:
41 N-Adamantyl-1-fluoropentylindole-3- carboxamide
42 (1-5-fluoropentyl)-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-
SB 209—LS 6921/DI 92 5
1 indole-3-carboxamide).
2 (DDDD) PB-22 (Other names include: 1-Pentyl-8-quinolinlyl
3 ester-1H-indole-2-carboxylic acid).
4 (EEEE) 5-Fluoro-PB-22 (Other names include:
5 1-(5-Fluropentyl)-8-quinolinyl ester1H-indole-3-carboxylic
6 acid).
7 (FFFF) Benocyclidine (Other names include: BCP, BTCP, and
8 Benzothiophenylcyclohexylpiperidine).
9 (GGGG) 25B-NBOMe (Other names include: 2C-B-NBOMe
10 and 4-Bromo-2,
11 5-dimenthoxy-N-[(2-Methozyphenyl)methyl]
12 benzeneethanamine).
13 (HHHH) APB (Other names include: (2-Aminopropyl)
14 Benzofuran).
15 (IIII) AB-PINACA
16 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-
17 indazole-3-carboxamide.
18 (JJJJ) AB-FUBINACA
19 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
20 1H-indazole-3-carboxamide).
21 (KKKK) ADB-PINACA
22 (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
23 indaole-3-carboxamide).
24 (LLLL) Fluoro ADBICA (N-(1-Amino-3,3-
25 dimethyl-1-oxobutan-2-yl)-(fluoropentyl)-1H-indole-3-
26 carboxamide).
27 (MMMM) APDB (Other names include: -EMA,
28 -Desoxy-MDA, and (2-Aminopropyl)-2,3-
29 dihydrobenzofuran).
30 (NNNN) THJ-2201 (Other names include: AM2201 indazole
31 analog, Fluoropentyl-JWH-018 indazole, and
32 5-Fluoro-THJ-018).
33 (OOOO) AM 2201 benzimidazole analog (Other names
34 include: FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-
35 benzo[d]imidazol-2-yl)(naphthalene-1-yl)methanone).
36 (PPPP) MN-25 (Other names include: 7-methoxy-1-
37 [2-(4-morpholinyl)ethyl]-N-[1S, 2S, 4R)-1,3,3-
38 trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide
39 and UR-12).
40 (QQQQ) FUB-PB-22 (Other names include:
41 Quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
42 (RRRR) FUD-PB-22 (Other names include:
SB 209—LS 6921/DI 92 6
1 Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
2 (SSSS) 5-Fluoro-AB-PINACA (Other names include:
3 AB-PINACA 5-fluoro analog and N-(1-amino-3-methyl1-
4 oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-
5 carboxaminde).
6 (TTTT) 4-MePPP (Other names include:
7 4-methyl-alpha-pyrrolidinopropiophenone).
8 (UUUU) alpha-PBP (Other names include:
9 Alpha-pyrrolidinobutiophenone).
10 (VVVV) AB-CHMINACA (Other names include:
11 (N-[1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethy
12 l)-1H-indazole-3-carboxamide).
13 (WWWW) Mexedrone
14 (3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-one).
15 (XXXX) MT-45,
16 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine).
17 (YYYY) methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-
18 carboxamido) -3,3-dimethylbutanoate [5F-ADB;
19 5F-MDMB-PINACA].
20 (ZZZZ) methyl 2-(1-(5-fluoropentyl)-1H- indazole-3-
21 carboxamido)-3-methylbutanoate [5F-AMB].
22 (AAAAA) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)
23 -1-(4-fluorobenzyl)- 1H-indazole-3-carboxamide
24 [ADB-FUBINACA].
25 (BBBBB) N-(adamantan-1-yl)-1-(5-fluoropentyl)-
26 1H-indazole-3- carboxamide [5F-APINACA, 5F-AKB48].
27 (CCCCC) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-
28 carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA,
29 MMB-CHMINACA].
30 (DDDDD) methyl 2-(1-(4-fluorobenzyl)-
31 1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate
32 [MDMB-FUBINACA].
33 (EEEEE) N-(1-amino-3,3-dimethyl-1 -oxobutan-2-yl)-1-
34 (cyclohexylmethyl)- 1H-indazole-3-carboxamide
35 [MAB-CHMINACA and ADB-CHMINACA].
36 (FFFFF) Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-
37 3-carboxamido)- 3-methylbutanoate [FUB-AMB,
38 MMB-FUBINACA, AMB-FUBINACA].
39 (GGGGG) 3,4-dichloro-N-[(1dimethylamino)cyclohexylme
40 thyl]benzamide) [AH7921].
41 (HHHHH) Naphthalen-1-yl 1-(5-fluoropentyl)-1
42 H-indole-3-carboxylate (trivial name: NM2201; CBL2201)
SB 209—LS 6921/DI 92 7
1 (IIIII) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1
2 H-indazole-3-carboxamide (trivial name:
3 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINA CA;
4 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78).
5 (JJJJJ) methyl 2-(1-(cyclohexylmethyl)-1
6 H-indole-3-carboxamido)-3-methylbutanoate (trivial names:
7 MMB-CHMICA, AMB-CHMICA).
8 (KKKKK) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1
9 H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name:
10 5F-CUMYL-P7AICA).
11 (LLLLL) N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-p
12 entanone (N-ethylpentylone, ephylone).
13 (MMMMM) Synthetic cathinone, 1-(1,3-benzodioxol-5-yl)-2-
14 (ethylamino)- pentan-1-one (N-ethylpentylone, ephylone) and
15 its optical, positional, and geometric isomers, salts, and salts
16 of isomers.
17 (NNNNN) ethyl
18 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
19 dimethylbutanoate (trivial name: 5F-EDMB-PINACA).
20 (OOOOO) methyl 2-(1-(5- fluoropentyl)-1H-indole-3-
21 carboxamido)-3,3-dimethylbutanoate (trivial name:
22 5F-MDMB-PICA).
23 (PPPPP) N- (adamantan- 1-yl)- 1-(4-fluorobenzyl)-
24 1H-indazole-3-carboxamide (trivial names: FUB-AKB48;
25 FUB-APINACA; AKB48 N- (4-FLUOROBENZYL)).
26 (QQQQQ) 1-(5- fluoropentyl)-N-(2-phenylpropan-2-yl)-
27 1H-indazole-3-carboxamide (trivial names:
28 5F-CUMYL-PINACA; SGT-25).
29 (RRRRR) (1-(4-fluorobenzyl)-1H-indol-3-
30 yl)(2,2,3,3-tetramethylcyclopropyl) methanone (trivial name:
31 FUB-144).
32 (SSSSS) 4F-MDMB-BINACA.
33 (TTTTT) N-ethylhexedrone
34 (2-(ethylamino)-1-phenylhexan-1-one).
35 (UUUUU) alpha-pyrrolidinohexanophenone
36 (1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.
37 (VVVVV) alpha-pyrrolidinohexiophenone; trivial name:
38 a-PHP.
39 (WWWWW) 4'-methyl-alpha-pyrrolidinohexiophenone
40 (1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one.
41 (XXXXX) 4-methyl-alphaethylaminopentiophenone
42 (2-(ethylamino)-1-(4-methylphenyl)pentan-1-one; trivial
SB 209—LS 6921/DI 92 8
1 name: 4–MEAP.
2 (YYYYY) 4'-methyl-alphapyrrolidinohexanophenone; trivial
3 name: MPHP.
4 (ZZZZZ) alphapyrrolidinoheptaphenone
5 (1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one; trivial name: PV8.
6 (AAAAAA) 4'-chloro-alphapyrrolidinovalerophenone (1-(4-
7 chlorophenyl)-2-(pyrrolidin-1- yl)pentan-1-one.
8 (BBBBBB) 4'-chloro-alphapyrrolidinopentiophenone; trivial
9 name: 4-chloro-a-PVP.
10 (CCCCCC) 4,4'-dimethylaminorex (common name:
11 4,4'-DMAR).
12 (2) Any compound structurally derived from
13 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by
14 substitution at the nitrogen atom of the indole ring by alkyl,
15 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
16 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
17 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
18 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
19 or not further substituted in the indole ring to any extent and
20 whether or not substituted in the naphthyl ring to any extent.
21 (3) Any compound structurally derived from 3-(1-naphthoyl)
22 pyrrole by substitution at the nitrogen atom of the pyrrole ring by
23 alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
24 cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
25 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl,
26 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl
27 group, whether or not further substituted in the pyrrole ring to any
28 extent and whether or not substituted in the naphthyl ring to any
29 extent.
30 (4) Any compound structurally derived from
31 1-(1-naphthylmethyl)indene by substitution at the 3-position of
32 the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
33 cycloalkylmethyl, cycloalkylethyl,
34 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
35 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
36 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
37 or not further substituted in the indene ring to any extent and
38 whether or not substituted in the naphthyl ring to any extent.
39 (5) Any compound structurally derived from 3-phenylacetylindole
40 by substitution at the nitrogen atom of the indole ring with alkyl,
41 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
42 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
SB 209—LS 6921/DI 92 9
1 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
2 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
3 or not further substituted in the indole ring to any extent and
4 whether or not substituted in the phenyl ring to any extent.
5 (6) Any compound structurally derived from
6 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position
7 of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
8 cycloalkylmethyl, cycloalkylethyl,
9 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
10 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
11 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
12 or not substituted in the cyclohexyl ring to any extent.
13 (7) Any compound containing a 3-(benzoyl)indole structure with
14 substitution at the nitrogen atom of the indole ring by alkyl,
15 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
16 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
17 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
18 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
19 or not further substituted in the indole ring to any extent and
20 whether or not substituted in the phenyl ring to any extent.
21 (8) Any compound, except bupropion or a compound listed under
22 a different schedule, structurally derived from
23 2-aminopropan-1-one by substitution at the 1-position with either
24 phenyl, naphthyl, or thiophene ring systems, whether or not the
25 compound is further modified:
26 (A) by substitution in the ring system to any extent with alkyl,
27 alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide
28 substituents, whether or not further substituted in the ring
29 system by one or more other univalent substituents;
30 (B) by substitution at the 3-position with an acyclic alkyl
31 substituent;
32 (C) by substitution at the 2-amino nitrogen atom with alkyl,
33 dialkyl, benzyl, or methoxybenzyl groups; or
34 (D) by inclusion of the 2-amino nitrogen atom in a cyclic
35 structure.
36 (9) Any compound structurally derived from 3-tetramethyl
37 cyclopropanoylindole with substitution at the nitrogen atom of the
38 indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
39 cycloalkylmethyl, cycloalkylethyl,
40 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl) ethyl,
41 1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3-
42 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
SB 209—LS 6921/DI 92 10
1 or not further substituted in the indole ring to any extent and
2 whether or not substituted in the tetramethylcyclopropyl ring to
3 any extent.
4 (10) Any compound containing a N-(1-adamantyl)-
5 1H-indazole-3-carboxamide structure with substitution at the
6 nitrogen atom of the indazole ring by an alkyl, haloalkyl,
7 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
8 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
9 1-(N-methyl-2-pyrrolidinyl)methyl,
10 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
11 group, whether or not further substituted at the nitrogen atom of
12 the carboxamide to any extent, whether or not further substituted
13 in the indazole ring to any extent, and whether or not further
14 substituted on the adamantyl ring system to any extent. An
15 example of this structural class includes AKB48.
16 (11) Any compound containing a N-(1-adamantyl)-
17 1H-indole-3-carboxamide structure with substitution at the
18 nitrogen atom of the indole ring by an alkyl, haloalkyl,
19 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
20 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
21 1-(N-methyl-2-pyrrolidinyl)methyl,
22 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
23 group, whether or not further substituted at the nitrogen atom of
24 the carboxamide to any extent, whether or not further substituted
25 in the indole ring to any extent, and whether or not further
26 substituted on the adamantyl ring system to any extent. An
27 example of this structural class includes STS-135.
28 (12) Any compound containing a 3-(1-adamantoyl)indole
29 structure with substitution at the nitrogen atom of the indole ring
30 by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
31 cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or
32 2-(4-morpholinyl)ethyl, 1-(N-methyl-2- pyrrolidinyl)methyl,
33 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
34 group, whether or not further substituted on the adamantyl ring
35 system to any extent. An example of this structural class includes
36 AM-1248.
37 (13) Any compound determined to be a synthetic drug by rule
38 adopted under IC 25-26-13-4.1.
39 SECTION 2. IC 35-48-1-17.4, AS ADDED BY P.L.61-2020,
40 SECTION 3, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
41 JULY 1, 2022]: Sec. 17.4. (a) Except as provided in subsections (b)
42 and (c), "isomer" means an optical isomer.
SB 209—LS 6921/DI 92 11
1 (b) "Isomer", as used in IC 35-48-2-4(d), means an optical,
2 positional, or geometric isomer.
3 (c) "Isomer", as used in section 7 of this chapter, means an optical
4 or geometric isomer. "Isomer" means an optical, positional, or
5 geometric isomer.
6 SECTION 3. IC 35-48-2-4, AS AMENDED BY P.L.10-2021,
7 SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
8 JULY 1, 2022]: Sec. 4. (a) The controlled substances listed in this
9 section are included in schedule I.
10 (b) Opiates. Any of the following opiates, including their isomers,
11 esters, ethers, salts, and salts of isomers, esters, and ethers, unless
12 specifically excepted by rule of the board or unless listed in another
13 schedule, whenever the existence of these isomers, esters, ethers, and
14 salts is possible within the specific chemical designation:
15 4-fluoroisobutyryl fentanyl
16 Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-
17 piperidinyl]-N-phenylacetamide) (9815)
18 Acetyl fentanyl (Other names include:
19 N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)
20 Acetylmethadol (9601)
21 Acrylfentanyl. Other name: N-(1-phenethylpiperidin-4-yl)-
22 N-phenylacrylamide
23 Allylprodine (9602)
24 Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
25 thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)
26 Alphacetylmethadol (9603)
27 Alphameprodine (9604)
28 Alphamethadol (9605)
29 Alphamethylfentanyl (9814)
30 Benzethidine (9606)
31 Beta-hydroxy-3-methylfentanyl (9831). Other name:
32 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl
33 ]-N-phenylpropanamide
34 Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
35 phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)
36 Betacetylmethadol (9607)
37 Betameprodine (9608)
38 Betamethadol (9609)
39 Betaprodine (9611)
40 Brorphine
41 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1yl)-N,N-di
42 ethylethan-1-amine (butonitazene)
SB 209—LS 6921/DI 92 12
1 Clonitazene (9612)
2 Cyclopentyl fentanyl. Other name:
3 N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide
4 Dextromoramide (9613)
5 Diampromide (9615)
6 Diethylthiambutene (9616)
7 N,N-diethyl-2-(2-(4-flourobenzyl)-5-nitro-1H-benzimidazol-
8 1-yl)ethan-1-amine (flunitazene)
9 N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)e
10 than-1-amine (metodesnitazene)
11 N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidaz
12 ol-1-yl)ethan-1-amine (metonitazene)
13 N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidaz
14 ol-1-yl)ethan-1-amine (protonitazene)
15 Difenoxin (9168)
16 Dimenoxadol (9617)
17 Dimepheptanol (9618)
18 Dimethylthiambutene (9619)
19 Dioxaphetyl butyrate (9621)
20 Dipipanone (9622)
21 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1yl)-N,N-diethyleth
22 an-1-amine (etodesnitazene; etazene)
23 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-
24 benzimidazole (N-pyrrolidino etonitazene; etonitazepyne)
25 Ethylmethylthiambutene (9623)
26 Etonitazene (9624)
27 Etoxeridine (9625)
28 Fentanyl related substances.
29 Furanyl fentanyl.
30 Furethidine (9626)
31 Hydroxypethidine (9627)
32 Isobutyryl fentanyl. Other name:
33 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide
34 Isotonitazene. Other name: N,N-diethyl-2-
35 (2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-
36 1-yl)ethan-1-amine)
37 Ketobemidone (9628)
38 Levomoramide (9629)
39 Levophenacylmorphan (9631)
40 Methoxyacetyl fentanyl. Other name:
41 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
42 3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-
SB 209—LS 6921/DI 92 13
1 piperidyl]-N-phenyl-propanimide](9813)
2 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
3 piperidinyl]-N-phenylpropanamide) (9833)
4 MDMB-4en-PINACA
5 4F-MDMB-BICA; 4-fluoro MDMB-BICA; 4F-MDMB-BUTICA;
6 Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,
7 3-dimethyl-butanoate
8 MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)
9 Morpheridine (9632)
10 N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl),
11 including any isomers, salts, or salts of isomers (9818)
12 N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl] 25 piperidin-4-yl]-
13 N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-
14 (2-thienyl)ethyl] -4- piperidinyl]- N-phenylpropanamide,
15 (beta-hydroxythiofentanyl)
16 N-(4-chlorophenyl)- N-(1-phenethylpiperidin-4-yl) isobutyramide
17 (para-chloroisobutyryl fentanyl)
18 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
19 acetamide (ocfentanil)
20 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4 -yl) butyramide
21 (para-fluorobutyryl fentanyl)
22 N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known
23 as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (butyryl
24 fentanyl)
25 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl
26 fentanyl)
27 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin -4-yl) butyramide
28 (para-methoxybutyryl fentanyl)
29 N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
30 (thenylfentanyl), including any isomers, salts, or salts of isomers
31 (9834)
32 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl
33 fentanyl)
34 N-(1-phenethylpiperidin-4-yl)- Nphenylcyclopentanecarboxamide
35 (cyclopentyl fentanyl)
36 Noracymethadol (9633)
37 Norlevorphanol (9634)
38 Normethadone (9635)
39 Norpipanone (9636)
40 Ocfentanil. Other name:
41 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
42 acetamide
SB 209—LS 6921/DI 92 14
1 Ortho-fluorofentanyl or 2-fluorofentanyl. Other name:
2 N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide
3 Para-chloroisobutyryl fentanyl. Other name:
4 N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide
5 Para-fluorobutyryl fentanyl. Other name:
6 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
7 Para-fluorofentanyl (N-(4-fluorophenyl)-N-
8 [1-(2-phenethyl)-4-piperidinyl] propanamide (9812)
9 Para-methoxybutyryl fentanyl. Other name:
10 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
11 Phenadoxone (9637)
12 Phenampromide (9638)
13 Phenomorphan (9647)
14 Phenoperidine (9641)
15 PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)
16 Piritramide (9642)
17 Proheptazine (9643)
18 Properidine (9644)
19 Propiram (9649)
20 Racemoramide (9645)
21 Tetrahydrofuranyl fentanyl. Other name:
22 N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carb
23 oxamide
24 Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-
25 piperidinyl]-propanamide) (9835)
26 Tilidine (9750)
27 Trimeperidine (9646)
28 U47700 (3,4-dichloro- N- [2-dimethylamino)cyclohexyl]-
29 N-methyl- benzamide)
30 Valeryl fentanyl. Other name:
31 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide
32 (c) Opium derivatives. Any of the following opium derivatives, their
33 salts, isomers, and salts of isomers, unless specifically excepted by rule
34 of the board or unless listed in another schedule, whenever the
35 existence of these salts, isomers, and salts of isomers is possible within
36 the specific chemical designation:
37 Acetorphine (9319)
38 Acetyldihydrocodeine (9051)
39 Benzylmorphine (9052)
40 Codeine methylbromide (9070)
41 Codeine-N-Oxide (9053)
42 Cyprenorphine (9054)
SB 209—LS 6921/DI 92 15
1 Desomorphine (9055)
2 Dihydromorphine (9145)
3 Drotebanol (9335)
4 Etorphine (except hydrochloride salt) (9056)
5 Heroin (9200)
6 Hydromorphinol (9301)
7 Methyldesorphine (9302)
8 Methyldihydromorphine (9304)
9 Morphine methylbromide (9305)
10 Morphine methylsulfonate (9306)
11 Morphine-N-Oxide (9307)
12 Myrophine (9308)
13 Nicocodeine (9309)
14 Nicomorphine (9312)
15 Normorphine (9313)
16 Pholcodine (9314)
17 Thebacon (9315)
18 (d) Hallucinogenic substances. Unless specifically excepted or
19 unless listed in another schedule, any material, compound, mixture, or
20 preparation which contains any quantity of the following
21 hallucinogenic, psychedelic, or psychogenic substances, their salts,
22 isomers, and salts of isomers whenever the existence of these salts,
23 isomers, and salts of isomers is possible within the specific chemical
24 designation (for purposes of this subsection only, the term "isomer"
25 includes the optical, position, and geometric isomers): designation:
26 (1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:
27 TCPy.
28 (2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some trade or
29 other names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine;
30 4-Bromo-2, 5-DMA.
31 (3) 4-Bromo-2, 5-dimethoxyphenethylamine (7392). Some trade
32 or other names:
33 2-[4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;
34 alpha-desmethyl DOB; 2C-B, Nexus.
35 (4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name:
36 DOET.
37 (5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348).
38 Other name: 2C-T-7.
39 (6) 2, 5-Dimethoxyamphetamine (7396). Some trade or other
40 names: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.
41 (7) 4-Methoxyamphetamine (7411). Some trade or other names:
42 4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine;
SB 209—LS 6921/DI 92 16
1 PMA.
2 (8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). Other
3 Name: MMDA.
4 (9) 5-Methoxy-N, N-diisopropyltryptamine, including any
5 isomers, salts, or salts of isomers (7439). Other name:
6 5-MeO-DIPT.
7 (10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some trade
8 and other names: 4-methyl-2,
9 5-dimethoxy-a-methylphenethylamine; DOM; and STP.
10 (11) 3, 4-methylenedioxy amphetamine (7400). Other name:
11 MDA.
12 (12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Other
13 names: N-ethyl-alpha-methyl-3,4(methylenedioxy)
14 phenethylamine; N-ethyl MDA; MDE; and MDEA.
15 (13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).
16 (14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.
17 (15) Alpha-ethyltryptamine (7249). Some trade and other names:
18 Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine;
19 3-(2-aminobutyl) indole; [alpha]-ET; and AET.
20 (16) Alpha-methyltryptamine (7432). Other name: AMT.
21 (17) Bufotenine (7433). Some trade and other names:
22 3-(B-Dimethylaminoethyl)-5-hydroxyindole;
23 3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin;
24 5-hydroxy-N, N-dimethyltryptamine; mappine.
25 (18) Diethyltryptamine (7434). Some trade or other names: N,
26 N-Diethyltryptamine; DET.
27 (19) Dimethyltryptamine (7435). Some trade or other names:
28 DMT.
29 (20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b,
30 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido
31 (1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.
32 (21) Lysergic acid diethylamide (7315). Other name: LSD.
33 (22) Marijuana (7360).
34 (23) Mescaline (7381).
35 (24) Parahexyl (7374). Some trade or other names:
36 3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6,
37 9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.
38 (25) Peyote (7415), including:
39 (A) all parts of the plant that are classified botanically as
40 lophophora williamsii lemaire, whether growing or not;
41 (B) the seeds thereof;
42 (C) any extract from any part of the plant; and
SB 209—LS 6921/DI 92 17
1 (D) every compound, manufacture, salt, derivative, mixture, or
2 preparation of the plant, its seeds, or extracts.
3 (26) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.
4 (27) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Other
5 names: N-hydroxy-alpha-methyl-3,4
6 (methylenedioxy)phenethylamine; and N-hydroxy MDA.
7 (28) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.
8 (29) Psilocybin (7437).
9 (30) Psilocyn (7438).
10 (31) Tetrahydrocannabinols (7370), including synthetic
11 equivalents of the substances contained in the plant, or in the
12 resinous extractives of Cannabis, sp. and synthetic substances,
13 derivatives, and their isomers with similar chemical structure and
14 pharmacological activity such as:
15 (A) ð
1
cis or trans tetrahydrocannabinol, and their optical
16 isomers;
17 (B) ð
6
cis or trans tetrahydrocannabinol, and their optical
18 isomers; and
19 (C) ð
3,
4 cis or trans tetrahydrocannabinol, and their optical
20 isomers.
21 Since nomenclature of these substances is not internationally
22 standardized, compounds of these structures, regardless of
23 numerical designation of atomic positions are covered. Other
24 name: THC.
25 (32) Ethylamine analog of phencyclidine (7455). Some trade or
26 other names: N-Ethyl-1-phenylcyclohexylamine;
27 (1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl)
28 ethylamine; cyclohexamine; PCE.
29 (33) Pyrrolidine analog of phencyclidine (7458). Some trade or
30 other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCP
y; PHP.
31 (34) Thiophene analog of phencyclidine (7470). Some trade or
32 other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl
33 Analog of Phencyclidine; TPCP.
34 (35) Salvia divinorum or salvinorin A, including:
35 (A) all parts of the plant that are classified botanically as salvia
36 divinorum, whether growing or not;
37 (B) the seeds of the plant;
38 (C) any extract from any part of the plant; and
39 (D) every compound, manufacture, salt, derivative, mixture, or
40 preparation of the plant, its seeds, or extracts.
41 (36) 5-Methoxy-N,N-Dimethyltryptamine. Some trade or other
42 names: 5-methoxy-3-[2- (dimethylamino)ethyl]indole;
SB 209—LS 6921/DI 92 18
1 5-MeO-DMT.
2 (37) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
3 (38) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
4 (39) 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C).
5 (40) 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I).
6 (41) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-2).
7 (42) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine
8 (2C-T-4).
9 (43) 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).
10 (44) 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N).
11 (45) 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P).
12 (46) Deschloroketamine (2-Phenyl-2-
13 (methylamino)cyclohexanone).
14 (47) 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-
15 ethyltryptamine).
16 (48) N-methyltryptamine (1H-Indole-3-ethanamine, N-methyl-).
17 (e) Depressants. Unless specifically excepted in a rule adopted by
18 the board or unless listed in another schedule, any material, compound,
19 mixture, or preparation which contains any quantity of the following
20 substances having a depressant effect on the central nervous system,
21 including its salts, isomers, and salts of isomers whenever the existence
22 of such salts, isomers, and salts of isomers is possible within the
23 specific chemical designation:
24 Etizolam (4-(2- chlorophenyl)-2- ethyl-9- methyl- 6H-
25 thieno[3,2-f] [1,2,4] triazolo[4,3-a] [1,4diazepine) (other names
26 include: Etilaam, Etizest, Depas, Etizola, Sedekopan, and
27 Pasaden)
28 Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-
29 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)
30 Gamma-hydroxybutyric acid (other names include GHB;
31 gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodium
32 oxybate; sodium oxybutyrate) (2010)
33 Mecloqualone (2572)
34 Methaqualone (2565)
35 (f) Stimulants. Unless specifically excepted or unless listed in
36 another schedule, any material, compound, mixture, or preparation that
37 contains any quantity of the following substances having a stimulant
38 effect on the central nervous system, including its salts, isomers, and
39 salts of isomers:
40 ([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-
41 dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590)
42 Aminorex (1585). Other names: aminoxaphen;
SB 209—LS 6921/DI 92 19
1 2-amino-5-phenyl-2-oxazoline; or
2 4,5-dihydro-5-phenyl-2-oxazolamine.
3 Benzylone, 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan
4 -1-one. Synonyms: BMDP, N-benzyl methylone,
5 3,4-Methylenedioxy-Nbenzylcathinone,
6 N-benzyl-3,4-methylenedioxycathinone.
7 Cathinone (1235). Some trade or other names:
8 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone;
9 2-aminopropiophenone; and norephedrone.
10 Fenethylline (1503).
11 N-Benzylpiperazine (7493). Other names: BZP; and
12 1-benzylpiperazine.
13 N-ethylamphetamine (1475).
14 Methcathinone (1237). Some other trade names:
15 2-Methylamino-1-Phenylpropan-I-one; Ephedrone;
16 Monomethylpropion; UR 1431.
17 N, N-dimethylamphetamine (1480). Other names: N,
18 N-alpha-trimethyl-benzeneethanamine; and N,
19 N-alpha-trimethylphenethylamine.
20 (g) Synthetic drugs as defined in IC 35-31.5-2-321.
SB 209—LS 6921/DI 92 20
COMMITTEE REPORT
Madam President: The Senate Committee on Corrections and
Criminal Law, to which was referred Senate Bill No. 209, has had the
same under consideration and begs leave to report the same back to the
Senate with the recommendation that said bill be AMENDED as
follows:
Page 1, between the enacting clause and line 1, begin a new
paragraph and insert:
"SECTION 1. IC 35-31.5-2-321, AS AMENDED BY P.L.61-2020,
SECTION 2, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 321. "Synthetic drug" means:
(1) a substance containing one (1) or more of the following
chemical compounds, including an analog of the compound:
(A) JWH-015 ((2-Methyl-1-propyl-1H-
indol-3-yl)-1-naphthalenylmethanone).
(B) JWH-018 (1-pentyl-3-(1-naphthoyl)indole).
(C) JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole).
(D) JWH-073 (naphthalen-1-yl-(1-butylindol-3-yl)methanone).
(E) JWH-081 (4-methoxynaphthalen- 1-yl- (1-pentylindol-
3-yl)methanone).
(F) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
(G) JWH-200 ((1-(2-morpholin-4-ylethyl)indol-3-yl)-
naphthalen-1-yl-methanone).
(H) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole).
(I) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole).
(J) JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
(K) HU-210 ((6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl-
3-(2-methyloctan-2-yl)-
6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol).
(L) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl-
3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo
[c]chromen-1-ol).
(M) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-
(2-methyloctan- 2-yl)phenyl]-
7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).
(N) HU-331 (3-hydroxy-2- [(1R,6R)-3-methyl-6-
(1-methylethenyl)-2 -cyclohexen-1-yl]-5
-pentyl-2,5-cyclohexadiene-1,4-dione).
(O) CP 55,940
(2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-
5- (2-methyloctan-2-yl)phenol).
SB 209—LS 6921/DI 92 21
(P) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5-
(2-methyloctan-2-yl)phenol) and its homologues, or
2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)
phenol), where side chain n=5, and homologues where side
chain n=4, 6, or 7.
(Q) WIN 55212-2
((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)
pyrrolo [1,2,3-de)- 1,4- benzoxazin-
6-yl]-1-napthalenylmethanone).
(R) RCS-4 ((4-methoxyphenyl)
(1-pentyl-1H-indol-3-yl)methanone).
(S) RCS-8 (1-(1-(2-cyclohexylethyl)-1H-
indol-3-yl)-2-(2-methoxyphenyl)ethanone).
(T) 4-Methylmethcathinone. Other name: mephedrone.
(U) 3,4-Methylenedioxymethcathinone. Other name:
methylone.
(V) Fluoromethcathinone.
(W) 4-Methoxymethcathinone. Other name: methedrone.
(X) 4-Ethylmethcathinone (4-EMC).
(Y) Methylenedioxypyrovalerone. Other name: MDPV.
(Z) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole.
(AA) JWH-098, or
1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole.
(BB) JWH-164, or
1-pentyl-3-(7-methoxy-1-naphthoyl)indole.
(CC) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole.
(DD) JWH-201, or
1-pentyl-3-(4-methoxyphenylacetyl)indole.
(EE) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole.
(FF) AM-694, or
1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
(GG) CP 50,556-1, or
[(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpe
ntan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1
-yl] acetate.
(HH) Dimethylheptylpyran, or DMHP.
(II) 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP.
(JJ) 6-APB [6-(2-aminopropyl)benzofuran].
(LL) 7-hydroxymitragynine.
(MM) á-PPP [á-pyrrolidinopropiophenone].
(NN) á-PVP (desmethylpyrovalerone).
(OO) AM-251.
SB 209—LS 6921/DI 92 22
(PP) AM-1241.
(QQ) AM-2201.
(RR) AM-2233.
(SS) Buphedrone (á-methylamino-butyrophenone (MABP)).
(TT) Butylone.
(UU) CP-47,497-C7.
(VV) CP-47,497-C8.
(WW) Desoxypipradol.
(XX) Ethylone.
(YY) Eutylone.
(ZZ) Flephedrone.
(AAA) JWH-011.
(BBB) JWH-020.
(CCC) JWH-022.
(DDD) JWH-030.
(EEE) JWH-182.
(FFF) JWH-302.
(GGG) MDAI [5,6-methylenedioxy-2-aminoindane].
(HHH) Mitragynine.
(III) Naphyrone.
(JJJ) Pentedrone.
(LLL) Pentylone.
(MMM) Methoxetamine
[2-(3-methoxyphenyl)-2-(ethylamino)- cyclohexanone].
(NNN) A796,260 [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-
(2,2,3,3-tetramethylcyclopropyl)methanone].
(OOO) AB-001[(1s,3s)-admantan-1-yl)
(1-pentyl-1H-indol-3-yl)methanone] or [1-Pentyl-3-
(1-adamantoyl)indole].
(PPP) AM-356 [Methanandamide].
(QQQ) AM 1248 [1-[(1-methyl-2- piperidinyl) methyl]-
1H-indol-3-yl] tricyclo[3.3.1.13,7] dec-1-yl-methanone]or
[(1-[(N-methylpiperindin-2-yl)
Methyl]-3-(Adamant-1-oyl)indole)].
(RRR) AM 2233 Azepane isomer [(2-iodophenyl)
(1-(1-methylazepan-3-yl)- 1H-indol-3-yl)methanone].
(SSS) CB-13 [1-Naphthalenyl
[4-(pentyoxy)- 1-naphthalenyl]methanone].
(TTT) UR-144 [(1-pentyl-1H-indol-3-yl)
(2,2,3,3-tetramethylcyclopropyl)-methanone].
(UUU) URB 597 [(3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)-
cyclohexylcarbamate].
SB 209—LS 6921/DI 92 23
(VVV) URB602 [[1,1'-biphenyl]- 3-yl-carbamic acid,
cyclohexyl ester].
(WWW) URB 754 [6-methyl-2-[(4-methylphenyl)
amino]-1-benzoxazin-4-one].
(XXX) XLR-11 or 5-fluoro UR-144
(1-(5-fluoropentyl)-1H-indol-3-yl)
(2,2,3,3-tetramethylcyclopropyl)methanone].
(YYY) AKB48 (Other names include:
N-Adamantyl-1-pentyl-1H-Indazole-3-carboxamide;
1-pentyl-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-indazole-3-
carboxamide).
(ZZZ) 25I-NBOMe (Other names include:
4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-
benzeneethanamine);
2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
methyl]ethanamine).
(AAAA) 2C-C-NBOMe (Other names include: 25C-NBOMe;
2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
methyl]ethanamine;
2,5-Dimethoxy-4-chloro-N-(2-methoxybenzyl)
phenethylamine).
(BBBB) 2NE-1 (Other names include: 1-Pentyl-3-
(1-adamantylamido)indole).
(CCCC) STS-135 (Other names include:
N-Adamantyl-1-fluoropentylindole-3- carboxamide
(1-5-fluoropentyl)-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-
indole-3-carboxamide).
(DDDD) PB-22 (Other names include: 1-Pentyl-8-quinolinlyl
ester-1H-indole-2-carboxylic acid).
(EEEE) 5-Fluoro-PB-22 (Other names include:
1-(5-Fluropentyl)-8-quinolinyl ester1H-indole-3-carboxylic
acid).
(FFFF) Benocyclidine (Other names include: BCP, BTCP, and
Benzothiophenylcyclohexylpiperidine).
(GGGG) 25B-NBOMe (Other names include: 2C-B-NBOMe
and 4-Bromo-2,
5-dimenthoxy-N-[(2-Methozyphenyl)methyl]
benzeneethanamine).
(HHHH) APB (Other names include: (2-Aminopropyl)
Benzofuran).
(IIII) AB-PINACA
(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-
SB 209—LS 6921/DI 92 24
indazole-3-carboxamide.
(JJJJ) AB-FUBINACA
(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide).
(KKKK) ADB-PINACA
(N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
indaole-3-carboxamide).
(LLLL) Fluoro ADBICA (N-(1-Amino-3,3-
dimethyl-1-oxobutan-2-yl)-(fluoropentyl)-1H-indole-3-
carboxamide).
(MMMM) APDB (Other names include: -EMA,
-Desoxy-MDA, and (2-Aminopropyl)-2,3-
dihydrobenzofuran).
(NNNN) THJ-2201 (Other names include: AM2201 indazole
analog, Fluoropentyl-JWH-018 indazole, and
5-Fluoro-THJ-018).
(OOOO) AM 2201 benzimidazole analog (Other names
include: FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-
benzo[d]imidazol-2-yl)(naphthalene-1-yl)methanone).
(PPPP) MN-25 (Other names include: 7-methoxy-1-
[2-(4-morpholinyl)ethyl]-N-[1S, 2S, 4R)-1,3,3-
trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide
and UR-12).
(QQQQ) FUB-PB-22 (Other names include:
Quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
(RRRR) FUD-PB-22 (Other names include:
Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
(SSSS) 5-Fluoro-AB-PINACA (Other names include:
AB-PINACA 5-fluoro analog and N-(1-amino-3-methyl1-
oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-
carboxaminde).
(TTTT) 4-MePPP (Other names include:
4-methyl-alpha-pyrrolidinopropiophenone).
(UUUU) alpha-PBP (Other names include:
Alpha-pyrrolidinobutiophenone).
(VVVV) AB-CHMINACA (Other names include:
(N-[1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethy
l)-1H-indazole-3-carboxamide).
(WWWW) Mexedrone
(3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-one).
(XXXX) MT-45,
(1-cyclohexyl-4-(1,2-diphenylethyl)piperazine).
SB 209—LS 6921/DI 92 25
(YYYY) methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-
carboxamido) -3,3-dimethylbutanoate [5F-ADB;
5F-MDMB-PINACA].
(ZZZZ) methyl 2-(1-(5-fluoropentyl)-1H- indazole-3-
carboxamido)-3-methylbutanoate [5F-AMB].
(AAAAA) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)
-1-(4-fluorobenzyl)- 1H-indazole-3-carboxamide
[ADB-FUBINACA].
(BBBBB) N-(adamantan-1-yl)-1-(5-fluoropentyl)-
1H-indazole-3- carboxamide [5F-APINACA, 5F-AKB48].
(CCCCC) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA,
MMB-CHMINACA].
(DDDDD) methyl 2-(1-(4-fluorobenzyl)-
1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate
[MDMB-FUBINACA].
(EEEEE) N-(1-amino-3,3-dimethyl-1 -oxobutan-2-yl)-1-
(cyclohexylmethyl)- 1H-indazole-3-carboxamide
[MAB-CHMINACA and ADB-CHMINACA].
(FFFFF) Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-
3-carboxamido)- 3-methylbutanoate [FUB-AMB,
MMB-FUBINACA, AMB-FUBINACA].
(GGGGG) 3,4-dichloro-N-[(1dimethylamino)cyclohexylme
thyl]benzamide) [AH7921].
(HHHHH) Naphthalen-1-yl 1-(5-fluoropentyl)-1
H-indole-3-carboxylate (trivial name: NM2201; CBL2201)
(IIIII) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1
H-indazole-3-carboxamide (trivial name:
4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINA CA;
4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78).
(JJJJJ) methyl 2-(1-(cyclohexylmethyl)-1
H-indole-3-carboxamido)-3-methylbutanoate (trivial names:
MMB-CHMICA, AMB-CHMICA).
(KKKKK) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1
H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name:
5F-CUMYL-P7AICA).
(LLLLL) N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-p
entanone (N-ethylpentylone, ephylone).
(MMMMM) Synthetic cathinone, 1-(1,3-benzodioxol-5-yl)-2-
(ethylamino)- pentan-1-one (N-ethylpentylone, ephylone) and
its optical, positional, and geometric isomers, salts, and salts
of isomers.
SB 209—LS 6921/DI 92 26
(NNNNN) ethyl
2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate (trivial name: 5F-EDMB-PINACA).
(OOOOO) methyl 2-(1-(5- fluoropentyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate (trivial name:
5F-MDMB-PICA).
(PPPPP) N- (adamantan- 1-yl)- 1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide (trivial names: FUB-AKB48;
FUB-APINACA; AKB48 N- (4-FLUOROBENZYL)).
(QQQQQ) 1-(5- fluoropentyl)-N-(2-phenylpropan-2-yl)-
1H-indazole-3-carboxamide (trivial names:
5F-CUMYL-PINACA; SGT-25).
(RRRRR) (1-(4-fluorobenzyl)-1H-indol-3-
yl)(2,2,3,3-tetramethylcyclopropyl) methanone (trivial name:
FUB-144).
(SSSSS) 4F-MDMB-BINACA.
(TTTTT) N-ethylhexedrone
(2-(ethylamino)-1-phenylhexan-1-one).
(UUUUU) alpha-pyrrolidinohexanophenone
(1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.
(VVVVV) alpha-pyrrolidinohexiophenone; trivial name:
a-PHP.
(WWWWW) 4'-methyl-alpha-pyrrolidinohexiophenone
(1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one.
(XXXXX) 4-methyl-alphaethylaminopentiophenone
(2-(ethylamino)-1-(4-methylphenyl)pentan-1-one; trivial
name: 4–MEAP.
(YYYYY) 4'-methyl-alphapyrrolidinohexanophenone; trivial
name: MPHP.
(ZZZZZ) alphapyrrolidinoheptaphenone
(1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one; trivial name: PV8.
(AAAAAA) 4'-chloro-alphapyrrolidinovalerophenone (1-(4-
chlorophenyl)-2-(pyrrolidin-1- yl)pentan-1-one.
(BBBBBB) 4'-chloro-alphapyrrolidinopentiophenone; trivial
name: 4-chloro-a-PVP.
(CCCCCC) 4,4'-dimethylaminorex (common name:
4,4'-DMAR).
(2) Any compound structurally derived from
3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by
substitution at the nitrogen atom of the indole ring by alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
SB 209—LS 6921/DI 92 27
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indole ring to any extent and
whether or not substituted in the naphthyl ring to any extent.
(3) Any compound structurally derived from 3-(1-naphthoyl)
pyrrole by substitution at the nitrogen atom of the pyrrole ring by
alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl,
1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl
group, whether or not further substituted in the pyrrole ring to any
extent and whether or not substituted in the naphthyl ring to any
extent.
(4) Any compound structurally derived from
1-(1-naphthylmethyl)indene by substitution at the 3-position of
the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indene ring to any extent and
whether or not substituted in the naphthyl ring to any extent.
(5) Any compound structurally derived from 3-phenylacetylindole
by substitution at the nitrogen atom of the indole ring with alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indole ring to any extent and
whether or not substituted in the phenyl ring to any extent.
(6) Any compound structurally derived from
2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position
of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not substituted in the cyclohexyl ring to any extent.
(7) Any compound containing a 3-(benzoyl)indole structure with
substitution at the nitrogen atom of the indole ring by alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
SB 209—LS 6921/DI 92 28
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indole ring to any extent and
whether or not substituted in the phenyl ring to any extent.
(8) Any compound, except bupropion or a compound listed under
a different schedule, structurally derived from
2-aminopropan-1-one by substitution at the 1-position with either
phenyl, naphthyl, or thiophene ring systems, whether or not the
compound is further modified:
(A) by substitution in the ring system to any extent with alkyl,
alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide
substituents, whether or not further substituted in the ring
system by one or more other univalent substituents;
(B) by substitution at the 3-position with an acyclic alkyl
substituent;
(C) by substitution at the 2-amino nitrogen atom with alkyl,
dialkyl, benzyl, or methoxybenzyl groups; or
(D) by inclusion of the 2-amino nitrogen atom in a cyclic
structure.
(9) Any compound structurally derived from 3-tetramethyl
cyclopropanoylindole with substitution at the nitrogen atom of the
indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl) ethyl,
1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indole ring to any extent and
whether or not substituted in the tetramethylcyclopropyl ring to
any extent.
(10) Any compound containing a N-(1-adamantyl)-
1H-indazole-3-carboxamide structure with substitution at the
nitrogen atom of the indazole ring by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
1-(N-methyl-2-pyrrolidinyl)methyl,
1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
group, whether or not further substituted at the nitrogen atom of
the carboxamide to any extent, whether or not further substituted
in the indazole ring to any extent, and whether or not further
substituted on the adamantyl ring system to any extent. An
example of this structural class includes AKB48.
(11) Any compound containing a N-(1-adamantyl)-
SB 209—LS 6921/DI 92 29
1H-indole-3-carboxamide structure with substitution at the
nitrogen atom of the indole ring by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
1-(N-methyl-2-pyrrolidinyl)methyl,
1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
group, whether or not further substituted at the nitrogen atom of
the carboxamide to any extent, whether or not further substituted
in the indole ring to any extent, and whether or not further
substituted on the adamantyl ring system to any extent. An
example of this structural class includes STS-135.
(12) Any compound containing a 3-(1-adamantoyl)indole
structure with substitution at the nitrogen atom of the indole ring
by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or
2-(4-morpholinyl)ethyl, 1-(N-methyl-2- pyrrolidinyl)methyl,
1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
group, whether or not further substituted on the adamantyl ring
system to any extent. An example of this structural class includes
AM-1248.
(13) Any compound determined to be a synthetic drug by rule
adopted under IC 25-26-13-4.1.
SECTION 2. IC 35-48-1-17.4, AS ADDED BY P.L.61-2020,
SECTION 3, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 17.4. (a) Except as provided in subsections (b)
and (c), "isomer" means an optical isomer.
(b) "Isomer", as used in IC 35-48-2-4(d), means an optical,
positional, or geometric isomer.
(c) "Isomer", as used in section 7 of this chapter, means an optical
or geometric isomer. "Isomer" means an optical, positional, or
geometric isomer.".
Page 2, between lines 17 and 18, begin a new line block indented
and insert:
"Brorphine".
Page 2, delete line 42, begin a new line block indented, and insert:
"2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-
benzimidazole (N-pyrrolidino etonitazene; etonitazepyne)".
Page 3, delete line 1.
Page 6, strike line 1.
SB 209—LS 6921/DI 92 30
Page 6, line 2, strike "includes the optical, position, and geometric
isomers):" and insert "designation:".
Renumber all SECTIONS consecutively.
and when so amended that said bill do pass.
(Reference is to SB 209 as introduced.)
YOUNG M, Chairperson
Committee Vote: Yeas 8, Nays 0.
SB 209—LS 6921/DI 92